Money Control Place
  • Politics
  • Business
  • Stocks
  • Investing
  • Politics
  • Business
  • Stocks
  • Investing

Money Control Place

Business

CVS Health to pull decongestants with phenylephrine off shelves

by October 20, 2023
October 20, 2023
CVS Health to pull decongestants with phenylephrine off shelves

U.S. pharmacy chain CVS Health said on Thursday it is pulling some of the most common decongestants with phenylephrine as the only active ingredient from its shelves and will no longer sell them.

The move comes after a panel of advisers to U.S. health regulators raised doubts over the efficacy of the ingredient.

Last month, the panel refused to back the effectiveness of oral over-the-counter (OTC) medicines made with phenylephrine, adding that no more trials were required to prove otherwise.

CVS said “other oral cough and cold products will continue to be offered to meet consumer needs.”

Phenylephrine was substituted for pseudoephedrine in many non-prescription cold and allergy medicines after the latter was restricted amid reports of abuse.

Phenylephrine is a major component used in some of popular products like Benadryl, Sudafed, GSK’s Advil and Kenvue’s Tylenol.

This post appeared first on NBC NEWS
0
FacebookTwitterGoogle +Pinterest
previous post
Tesla Stock Has High Expectations: A Strong Pop or Plunge
next post
World’s Largest Miners Confirmed For This Year’s Resourcing Tomorrow Event

Related Posts

Supreme Court declines to hear case challenging FDA...

October 12, 2023

American Eagle shares plunge 17% after it withdraws...

May 15, 2025

Federal student loans this fall will have the highest interest...

May 15, 2024

Lucid CEO steps down; EV maker plans to...

February 28, 2025

Honda recalls thousands of hybrids over electrical issue...

December 22, 2023

Average credit card balances jump 10% to a...

February 9, 2024

Oil executives bluntly criticize Trump tariffs and ‘drill,...

March 28, 2025

Prosecutors in Sam Bankman-Fried trial compare defense argument...

October 24, 2023

Trump Media tells shareholders how to block their...

April 20, 2024

UPS workers overwhelmingly approve new contract, ending strike...

August 23, 2023

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    • Vince Lanci: Silver’s London Liquidity Crisis — What’s Happening, What’s Next

    • Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027

    • Top 5 Canadian Mining Stocks This Week: JZR Gold Jumps 113 Percent

    • Tech Weekly: Broadcom and OpenAI Sign Deal, AMD and Oracle Announce Partnership

    • Finlay Minerals Announces Closing of Non-Brokered Private Placement of Flow-Through and Non-Flow-Through Units

    Categories

    • Business (1,400)
    • Investing (3,043)
    • Politics (3,699)
    • Stocks (1,823)
    • Uncategorized (20)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: MoneyControlPlace.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 moneycontrolplace.com | All Rights Reserved